The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The contribution of de novo coding mutations to autism spectrum disorder
Open accessAbstract
Whole exome sequencing has proven to be a powerful tool for understanding the genetic architecture of human disease. Here we apply it to more than 2,500 simplex families, each having a child with an autistic spectrum disorder. By comparing affected to unaffected siblings, we show that 13% of de novo missense mutations and 43% of de novo likely gene-disrupting (LGD) mutations contribute to 12% and 9% of diagnoses, respectively. Including copy number variants, coding de novo mutations contribute to about 30% of all simplex and 45% of female diagnoses. Almost all LGD mutations occur opposite wild-type alleles. LGD targets in affected females significantly overlap the targets in males of lower intelligence quotient (IQ), but neither overlaps significantly with targets in males of higher IQ. We estimate that LGD mutation in about 400 genes can contribute to the joint class of affected females and males of lower IQ, with an overlapping and similar number of genes vulnerable to contributory missense mutation. LGD targets in the joint class overlap with published targets for intellectual disability and schizophrenia, and are enriched for chromatin modifiers, FMRP-associated genes and embryonically expressed genes. Most of the significance for the latter comes from affected females.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“including that, prima facie , most proteins encoded by ASD risk genes are involved either in synaptic structure and function or chromatin modification and regulation of gene expression 38,46,47,58 (Fig. 3).”
From Autism spectrum disorder (2020) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rare inherited and de novo variants are major contributors to individual risk for autism spectrum disorder (ASD)”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Iossifov et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The application of this approach to exomes or whole genomes in large family samples has since become the most effective strategy for identifying ASD susceptibility genes (De Rubeis et al., 2014; Iossifov et al., 2014; Sanders et al., 2015; Satterstrom et al., 2018).”
From Getting to the cores of autism (2019) · cites this paper as Iossifov et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By contrast, de novo mutations, mostly copy number variants (CNVs) and gene disrupting point mutations, have larger individual effects, but collectively explain <5% of the overall liability 1-3 and far less of the heritability.”
From Identification of common genetic risk variants for autism spectrum disorder (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ASD affects 1-1.5% of individuals and is highly heritable, with both common and rare variants contributing to its etiology 1-4 .”
From Identification of common genetic risk variants for autism spectrum disorder (2019) · cites this paper as [3]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, for the majority of large CNVs, studies have not found evidence for the existence of a single driver gene (De Rubeis et al., 2014; Iossifov et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Iossifov et al., 2014
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For instance, several microdeletions lead to loss of various lengths of the C-terminal portion of Dock4 protein 19, 21, 26, which is responsible for its Rac1-activating ability 27.”
From Autism-like social deficit generated by Dock4 deficiency is rescued by restoration of Rac1 activity and NMDA receptor function. (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recent studies have identified a number of DOCK4 variations associated with ASD, including both single nucleotide variations (SNVs) and chromosome microdeletions or duplications (Supplementary Table 1) 18–26.”
From Autism-like social deficit generated by Dock4 deficiency is rescued by restoration of Rac1 activity and NMDA receptor function. (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Next-generation sequencing identified one intronic114, two missense133,134, and two nonsense variants in autism patients104,114, and the functional consequences of these variants remain to be established (Table 2u).”
From The WAVE complex in developmental and adulthood brain disorders (2025) · cites this paper as [133]
Experimental — accuracy not yet measuredIn the citing paper
“The major risk factors for autism spectrum disorder (ASD) are genetic and include a variety of rare and common alleles, including rare de novo copy number variants (CNVs)1 or protein-truncating SNPs and indels of large effect2 and common polygenic risk that is measured as the sum of thousands of common alleles with small effects3.”
From A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex (2022) · cites this paper as [2]
In the citing paper
“The possibility of a “female protective effect” (FPE) against ASD has been described extensively and has received consistent support from the results of genetic studies of de novo variants.4, 5, 6, 7, 8, 9, 10, 11, 12, 13”
From The female protective effect against autism spectrum disorder (2022) · cites this paper as [11]
In the citing paper
“Many types of ASD-associated de novo variants are observed more frequently in female cases.4, 5, 6, 7, 8, 9, 10, 11, 12, 13”
From The female protective effect against autism spectrum disorder (2022) · cites this paper as [11]
In the citing paper
“We also demonstrated that the genetic architecture in this self-reported cohort is similar to published, clinically confirmed ASD cohorts.3,4,7”
From Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes (2019) · cites this paper as [3]
In the citing paper
“Over the past decade, genomic studies focused on de novo, likely gene disrupting (dnLGD) variants (stopgain, frameshift, and essential splice site) have identified ~100 high-confidence ASD risk genes or loci.3,4”
From Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes (2019) · cites this paper as [3]
In the citing paper
“individuals with ASD have a two- to three-fold increase in the number of rare copy number variations (CNVs) and de novo loss-of-function (nonsense, frameshift, and splice site) variants compared to their unaffected siblings11–14.”
From Genome-wide detection of tandem DNA repeats that are expanded in autism (2020) · cites this paper as [12]
In the citing paper
“the application of two SNV callers identified 77 additional de novo SNVs previously missed 9.”
From Excess of rare, inherited truncating mutations in autism (2015) · cites this paper as [9]
In the citing paper
“In addition, we also validated by Sanger sequencing another 132 previously called 9 but not confirmed events, resulting in a total of 209 validated de novo SNVs and indels (Supplementary Table 2).”
From Excess of rare, inherited truncating mutations in autism (2015) · cites this paper as [9]
In the citing paper
“Most of these mutations also decrease IQ and ID is an important comorbidity of ASD (Buja et al., 2018; Iossifov et al., 2014), which is consistent with previous work identifying dozens of known severe, rare medical genetic syndromes associated with ASD (reviewed in (Abrahams and Geschwind, 2008; Geschwind, 2009)).”
From Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“Although each gene accounts for only a small fraction of cases, rare de novo variation is predicted to account for ~15% of ASD cases (Iossifov et al., 2014).”
From Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“As would be expected for variants with large effects, subjects that carry de novo mutations have lower non-verbal IQs than subjects who do not (Iossifov et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“It is estimated that de novo mutations of genes contribute in approximately 30% of cases, including 25% of boys and 45% of girls (Iossifov et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“Moreover, 20 of these lncRNAs have been shown to interact with microRNA (miRNA)–protein complexes, and 9 with the fragile X mental retardation protein (FMRP), whose mRNA targets are enriched in ASD risk genes9,10.”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [9]
In the citing paper
“In this regard, it is notable that the observed transcriptome changes are consistent with an ongoing process that is triggered largely by genetic and prenatal factors3,9,10,23, but that evolves during the first decade of brain development.”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [9]
In the citing paper
“We previously computed that genes with de novo (DN) likely gene-disruptive (LGD) mutations in children with autism spectrum disorders (ASD) have high vulnerability: disruptive mutations in many of these genes, the vulnerable autism genes, will have a high likelihood of resulting in ASD.”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“Moreover, the target genes in affected and unaffected individuals have length distributions that are closely matched (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“There are 39 such targets (10,18), and we previously estimated that ∼90% of these targets are true causal targets.”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“All gene classes enriched for autism targets show a decreased load of UR LGD variants, especially the FMRP-associated class, as previously noted (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“We also find a strong signal for biased transmission in the functional categories of genes previously associated with ASD (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“We computed that roughly half of the time in males, a DN LGD mutation within an autism gene will produce severe ASD (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“From recurrence and overlap analysis of DN LGD targets, we estimate ∼500 causative ASD target genes in the affected individuals with lower intelligence quotients (IQ), and these targets are enriched in certain functional classes (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“The increase in the rate of DN LGD mutation in affected children compared with the rate in their unaffected siblings was used to estimate the proportion (0.42) of 391 observed DN variants in the affected children that contribute to affected status (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“Although our previous work had shown that embryonic genes were enriched as DN targets (10), their involvement in transmission is greater than we would have predicted.”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“First, a substantial signal from transmission is seen in the set of “embryonic” genes (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“Thus, many severe mutations do not converge on one specific phenotype but instead seem to cause a range of clinical disorders74,76,80,81,84,87,91.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [76]
In the citing paper
“suggesting that females are affected by more severe genetic hits in ASD, an observation that has been replicated in exome-sequencing studies76,117.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [76]
In the citing paper
“This elevation of protein-compromising URVs was several times larger than an analogously elevated rate for de novo mutations”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [13]
In the citing paper
“These data yielded an elevation of about 0.03 such DNMs per exome, based on the difference between rates of 0.185 (95% CI 0.151-0.219) for individuals with schizophrenia12 and 0.156 (95% CI 0.139-0.174) for unaffected individuals13.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [13]
In the citing paper
“Subsets of human genes have been previously identified as “missense constrained” (based on a lack of functional coding variation in controls) or “loss-of-function intolerant” (based on a smaller-than-expected number of loss-of-function mutations in population-scale data)13,21.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [13]
In the citing paper
“ANK2 has been consistently associated with ASD (22,26,80) and also with cardiac arrhythmia (OMIM no.600919) (78).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“In the case of paternal age, one mediating mechanism lies in the increased rate of de novo SNV and CNV with advancing paternal age (22,24,25,43,44).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“To date, in addition to causal and highly penetrant genes and genomic loci identified before whole-exome sequencing (15,30), over 50 high-risk genes have emerged from the large-scale sequencing studies (21)(22)(23)(24)(25)(26), most under a model of autosomal dominant variation.”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“The model helps in the understanding of the relatively high risk for siblings of individuals diagnosed with ASD (13,46), the increased mutational burden in ASD probands compared with their unaffected siblings (22,28), etiological heterogeneity even within pairs of affected siblings (47,48) and, as we shall discuss further, the variable expressivity of certain loci (49,50) (Fig. 1).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“Rare genetic risk variation identified to date, in contrast, has a very substantial effect on individual risk.Recent whole-exome sequencing analyses of large ASD cohorts (21)(22)(23)(24)(25)(26)(27)(28)(29) have expanded the repertoire of known genes harboring ASD-linked mutations”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“Recent whole-exome sequencing analyses of large ASD cohorts (21)(22)(23)(24)(25)(26)(27)(28)(29) have expanded the repertoire of known genes harboring ASD-linked mutations that were previously identifiable only by traditional genetic approaches and targeted sequencing (14,15).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“CHD2 has been associated with ASD (22,23), ID (73), epilepsy (82,87) and photosensitivity (83).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“TBR1 has been implicated in ASD (21,22,25,26) and ID (73).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“Mutations in CHD2 have been detected in individuals with a diagnosis of ASD (22), ID (73) or epilepsy (82,83,87,89)”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“such rare high-confidence mutations tend to be significantly enriched in genes involved in synaptic functions, transcriptional regulation, and chromatin remodeling functions, and/or are downstream targets of the fragile X syndrome protein (FMRP) complex.1, 3”
From Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder (2018) · cites this paper as [3]
In the citing paper
“When considering known ASD-associated missense variants,3 we also found substantial enrichment (33%, 48/145, OR=2.21, P=0.0021) (Figure 1b).”
From Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder (2018) · cites this paper as [3]
In the citing paper
“Albeit rare, de novo mutations have emerged as substantial contributors to ASD risk [83, 165, 166, 254, 261, 309].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [165]
In the citing paper
“Chromodomain helicase DNA-binding protein 8 (CHD8), encoding a chromatin modifying gene on chromosome 14q11.2, is one of the high-penetrance ASD risk genes recently identified by sequencing studies [83, 165, 261, 347].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [165]
In the citing paper
“Using the WW data, we observe enrichment at an empirical P ≤ .05 for the synaptic co-expression network M13 [48], Mendelian disease genes [11], and both human (HARs) and primate-accelerated regions (PARs) [49]. None of these enrichments exceeded the experiment-wise corrected P ≤ .05.”
In the citing paper
“For example, FMRP biology has also been implicated in all three diagnoses [11].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationDNA methylation and epigenetic inheritance
Holliday, R. (1990) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1990.0015 · Cited by 2,290
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Self-citationRate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134
Spatio-temporal transcriptome of the human brain
Kang, H. J., Kawasawa, Y. I., Cheng, F., Zhu, Y., Xu, X., Li, M., Sousa, A. M. M., Pletikos, M., Meyer, K. A., Sedmak, G., et al. (2011) · Nature · doi:10.1038/nature10523 · Cited by 2,084
Self-citationDe novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Self-citation
Cited by
Sorted by citations
Items 201–300 of 1,014
Thrombospondin receptor α2δ-1 promotes synaptogenesis and spinogenesis via postsynaptic Rac1
Risher, W. C., Kim, N., Koh, S., Choi, J.-E., Mitev, P., Spence, E. F., Pilaz, L., Wang, D., Feng, G., Silver, D. L., et al. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201802057 · Cited by 162
Zhu, N., Welch, C. L., Wang, J., Allen, P. M., Gonzaga-Jauregui, C. G., Ma, L., King, A. K., Krishnan, U., Rosenzweig, E. B., Ivy, D. D., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0566-x · Cited by 162
Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders
Stessman, H. A. F., Willemsen, M. H., Fencková, M., Penn, O., Hoischen, A., Xiong, B., Wang, T., Hoekzema, K., Vives, L., Vogel, I., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.02.004 · Cited by 160
Self-citationDNA Damage and Repair in Human Reproductive Cells
Rodríguez, A. G., Gosálvez, J., Agarwal, A. K., Roy, R., & Johnston, S. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010031 · Cited by 160
Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders
Turner, T. N., Wilfert, A. B., Bakken, T. E., Bernier, R. A., Pepper, M. R., Zhang, Z., Torene, R. I., Retterer, K., & Eichler, E. E. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.11.003 · Cited by 159
Self-citationConvergence of Sex Differences and the Neuroimmune System in Autism Spectrum Disorder
McCarthy, M. M., & Wright, C. L. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.004 · Cited by 158
Autism Spectrum Disorder Genetics and the Search for Pathological Mechanisms
Manoli, D. S., & State, M. W. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20111608 · Cited by 159
Self-citationNew and emerging approaches to treat psychiatric disorders
Scangos, K. W., State, M. W., Miller, A. H., Baker, J. T., & Williams, L. M. (2023) · Nature Medicine · doi:10.1038/s41591-022-02197-0 · Cited by 164
Self-citationLow load for disruptive mutations in autism genes and their biased transmission
Iossifov, I., Levy, D., Allen, J., Ye, K., Ronemus, M., Lee, Y.-H., Yamrom, B., & Wigler, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516376112 · Cited by 156
Self-citationSomatic Mosaicism in the Human Genome
Freed, D. N., Stevens, E. L., & Pevsner, J. (2014) · Genes · doi:10.3390/genes5041064 · Cited by 156
Guo, H., Wang, T., Wu, H., Long, M., Coe, B. P., Li, H., Xun, G., Ou, J., Chen, B., Duan, G., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0247-z · Cited by 154
Self-citationJin, S. C., Dong, W., Kundishora, A. J., Panchagnula, S., Moreno-De-Luca, A., Furey, C. G., Allocco, A. A., Walker, R. L., Nelson-Williams, C. J., Smith, H. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1090-2 · Cited by 154
Self-citationTargeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms
D’Gama, A. M., Pochareddy, S., Li, M., Jamuar, S. S., Rodin, R. E., Lam, A.-T. N., Šestan, N., & Walsh, C. A. (2015) · Neuron · doi:10.1016/j.neuron.2015.11.009 · Cited by 153
Neuron-Glia Interactions in Neurodevelopmental Disorders
Kim, Y. S., Choi, J., & Yoon, B. (2020) · Cells · doi:10.3390/cells9102176 · Cited by 154
Regulation of NMDA glutamate receptor functions by the GluN2 subunits
Vieira, M., Yong, X. L. H., Roche, K. W., & Anggono, V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14970 · Cited by 151
Molecular cascades and cell type–specific signatures in ASD revealed by single-cell genomics
Wamsley, B., Bicks, L. K., Cheng, Y., Kawaguchi, R., Quintero, D., Grundman, J., Liu, J., Xiao, S., Hawken, N., Margolis, M., et al. (2024) · Science · doi:10.1126/science.adh2602 · Cited by 155
Wang, T., Shan, L., Du, L., Feng, J., Xu, Z., Staal, W., & Jia, F. (2015) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0786-1 · Cited by 152
Gene Length Matters in Neurons
Zylka, M. J., Simon, J. M., & Philpot, B. D. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.059 · Cited by 148
De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus
Furey, C. G., Choi, J., Jin, S. C., Zeng, X. Q., Timberlake, A. T., Nelson-Williams, C. J., Mansuri, M. S., Lu, Q., Durán, D., Panchagnula, S., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.019 · Cited by 148
Self-citationMutational Landscapes and Phenotypic Spectrum of SWI/SNF-Related Intellectual Disability Disorders
Bögershausen, N., & Wollnik, B. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00252 · Cited by 148
Curran, E. A., Dalman, C., Kearney, P. M., Kenny, L. C., Cryan, J. F., Dinan, T. G., & Khashan, A. S. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0846 · Cited by 146
Kumar, S., Reynolds, K., Ji, Y., Gu, R., Rai, S., & Zhou, C. J. (2019) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-019-9268-y · Cited by 147
Phan, B. N., Bohlen, J. F., Davis, B. A., Ye, Z., Chen, H.-Y., Mayfield, B., Sripathy, S. R., Page, S. C., Campbell, M. N., Smith, H. L., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0578-x · Cited by 146
Li, Y., Luo, Z.-Y., Hu, Y.-Y., Bi, Y.-W., Yang, J., Ming-an, L., Zou, W.-J., Li, S., Shen, T., Li, S.-J., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00884-z · Cited by 146
Autism spectrum disorders: from genes to neurobiology
Jeremy Willsey, A., & State, M. W. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.10.015 · Cited by 145
Self-citationMacroautophagy in CNS health and disease
Griffey, C. J., & Yamamoto, A. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00588-3 · Cited by 147
Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications
Wilfert, A. B., Sulovari, A., Turner, T. N., Coe, B. P., & Eichler, E. E. (2017) · Genome Medicine · doi:10.1186/s13073-017-0498-x · Cited by 144
Self-citationElectron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease
Henriques, B. J., Olsen, R. K. J., Gomes, C. M., & Bross, P. (2021) · Gene · doi:10.1016/j.gene.2021.145407 · Cited by 143
Imaging sex/gender and autism in the brain: Etiological implications
Lai, M., Lerch, J. P., Floris, D. L., Ruigrok, A. N. V., Pohl, A. L., Lombardo, M. V., & Baron‐Cohen, S. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23948 · Cited by 142
A framework for an evidence-based gene list relevant to autism spectrum disorder
Schaaf, C. P., Betancur, C., Yuen, R. K. C., Parr, J. R., Skuse, D., Gallagher, L., Bernier, R., Buchanan, J. A., Buxbaum, J. D., Chen, C., et al. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0231-2 · Cited by 144
Assessing the evidence for shared genetic risks across psychiatric disorders and traits
Martin, J., Taylor, M. J., & Lichtenstein, P. (2017) · Psychological Medicine · doi:10.1017/s0033291717003440 · Cited by 141
Recent ultra-rare inherited variants implicate new autism candidate risk genes
Wilfert, A. B., Turner, T. N., Murali, S. C., Hsieh, P., Sulovari, A., Wang, T., Coe, B. P., Guo, H., Hoekzema, K., Bakken, T. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00899-8 · Cited by 141
Self-citationJanecka, M., Mill, J., Basson, M. A., Goriely, A., Spiers, H., Reichenberg, A., Schalkwyk, L., & Fernandes, C. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.294 · Cited by 140
Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease
Johnson, M. R., Shkura, K., Langley, S. R., Delahaye‐Duriez, A., Srivastava, P. K., Hill, W. D., Rackham, O. J. L., Davies, G., Harris, S. E., Moreno‐Moral, A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4205 · Cited by 140
Won, H., Huang, J. I., Opland, C. K., Hartl, C., & Geschwind, D. H. (2019) · Nature Communications · doi:10.1038/s41467-019-10248-3 · Cited by 140
A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders
Gonzalez-Mantilla, A. J., Moreno-De-Luca, A., Ledbetter, D. H., & Martin, C. L. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2692 · Cited by 139
DNA Methylation and Susceptibility to Autism Spectrum Disorder
Tremblay, M. W., & Jiang, Y. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-120417-091431 · Cited by 139
Neocortical neurogenesis and the etiology of autism spectrum disorder
Packer, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.002 · Cited by 138
Codina‐Solà, M., Rodríguez‐Santiago, B., Homs, A., Santoyo‐López, J., Rigau, M., Laín, G. A., Campo, M. D., Gener, B., Gabau, E., Botella, M. P., et al. (2015) · Molecular Autism · doi:10.1186/s13229-015-0017-0 · Cited by 137
Dysregulation of Cortical Neuron DNA Methylation Profile in Autism Spectrum Disorder
Nardone, S., Sams, D. S., Zito, A., Reuveni, E., & Elliott, E. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx250 · Cited by 137
Nardone, S., & Elliott, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00329 · Cited by 138
Multidimensional Neuroanatomical Subtyping of Autism Spectrum Disorder
Hong, S., Valk, S. L., Martino, A. D., Milham, M. P., & Bernhardt, B. C. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx229 · Cited by 136
Gussow, A. B., Petrovski, S., Wang, Q., Allen, A. S., & Goldstein, D. B. (2016) · Genome biology · doi:10.1186/s13059-016-0869-4 · Cited by 135
Autism and Cancer Share Risk Genes, Pathways, and Drug Targets
Crawley, J. N., Heyer, W.-D., & LaSalle, J. M. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.01.001 · Cited by 134
De novo mutations and rare variants occurring in NMDA receptors
XiangWei, W., Jiang, Y., & Yuan, H. (2017) · Current Opinion in Physiology · doi:10.1016/j.cophys.2017.12.013 · Cited by 133
Guo, H., Duyzend, M., Coe, B. P., Baker, C. A., Hoekzema, K., Gerdts, J. A., Turner, T. N., Zody, M. C., Beighley, J. S., Murali, S. C., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0380-2 · Cited by 133
Self-citationThe Intolerance of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity
Petrovski, S., Gussow, A. B., Wang, Q., Halvorsen, M., Han, Y., Weir, W. H., Allen, A. S., & Goldstein, D. B. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005492 · Cited by 132
Xu, X., Li, C., Gao, X., Xia, K., Guo, H., Li, Y., Hao, Z., Zhang, L., Gao, D., Xu, C., et al. (2017) · Cell Research · doi:10.1038/cr.2017.132 · Cited by 132
Postsynaptic density proteins and their involvement in neurodevelopmental disorders
Kaizuka, T., & Takumi, T. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy022 · Cited by 131
Is advanced paternal age a health risk for the offspring?
Andersen, A. N., & Urhøj, S. K. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.12.019 · Cited by 131
Suetterlin, P., Hurley, S., Mohan, C., Riegman, K. L. H., Pagani, M., Caruso, A., Ellegood, J., Galbusera, A., Crespo‐Enríquez, I., Michetti, C., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy058 · Cited by 132
Genetic Associations between Voltage-Gated Calcium Channels and Psychiatric Disorders
Andrade, A., Brennecke, A., Mallat, S., Brown, J., Gomez-Rivadeneira, J., Czepiel, N., & Londrigan, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143537 · Cited by 131
Advances in epilepsy gene discovery and implications for epilepsy diagnosis and treatment
Symonds, J. D., Zuberi, S. M., & Johnson, M. R. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000433 · Cited by 128
The role of TGF-β superfamily signaling in neurological disorders
Kashima, R., & Hata, A. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx124 · Cited by 130
Merner, N. D., Chandler, M. R., Bourassa, C. V., Liang, B., Khanna, A. R., Dion, P. A., Rouleau, G. A., & Kahle, K. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00386 · Cited by 129
Takata, A., Ionita‐Laza, I., Gogos, J. A., Xu, B., & Karayiorgou, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.024 · Cited by 129
Disruption of mTOR and MAPK pathways correlates with severity in idiopathic autism
Rosina, E., Battan, B., Siracusano, M., Criscio, L. D., Hollis, F., Pacini, L., Curatolo, P., & Bagni, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0335-z · Cited by 129
A framework for the investigation of rare genetic disorders in neuropsychiatry
Sanders, S., Şahin, M., Hostyk, J. A., Thurm, A. E., Jacquemont, S., Avillach, P., Douard, E. A., Martin, C. L., Modi, M. E., Moreno-De-Luca, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0581-5 · Cited by 131
Self-citationThe Contribution of Mosaic Variants to Autism Spectrum Disorder
Freed, D. N., & Pevsner, J. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006245 · Cited by 128
From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms
Kabir, Z. D., Martínez-Rivera, A., & Rajadhyaksha, A. M. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0532-0 · Cited by 128
Sestan, N., & State, M. W. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.015 · Cited by 127
Self-citationPearson, B. L., Simon, J. M., McCoy, E. S., Salazar, G., Fragola, G., & Zylka, M. J. (2016) · Nature Communications · doi:10.1038/ncomms11173 · Cited by 127
Stephenson, J. R., Wang, X., Perfitt, T. L., Parrish, W. P., Shonesy, B. C., Marks, C. R., Mortlock, D. P., Nakagawa, T., Sutcliffe, J. S., & Colbran, R. J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2068-16.2017 · Cited by 127
Regulation of neuronal migration, an emerging topic in autism spectrum disorders
Reiner, O., Karzbrun, E., Kshirsagar, A., & Kaibuchi, K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13403 · Cited by 129
Whole genome sequencing in psychiatric disorders: the WGSPD consortium
(WGSPD), W. G. S. F. P. D., Sanders, S., Neale, B. M., Huang, H., Werling, D. M., An, J., Dong, S., Abecasis, G. R., Arguello, P. A., Blangero, J., et al. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0017-9 · Cited by 128
Self-citationiPSYCH-SSI-Broad Autism Group, St Pourcain, B., Robinson, E. B., Anttila, V, Sullivan, B. B., Maller, J., Golding, J., Skuse, D., Ring, S., Evans, D. M., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.198 · Cited by 125
Lazaro, M. T., Taxidis, J., Shuman, T., Bachmutsky, I., Ikrar, T., Santos, R., Marcello, G. M., Mylavarapu, A., Chandra, S., Foreman, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.006 · Cited by 125
Davenport, E. C., Szulc, B. R., Drew, J., Taylor, J., Morgan, T., Higgs, N. F., López-Doménech, G., & Kittler, J. T. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.092 · Cited by 125
Hermansky–Pudlak syndrome: Mutation update
Huizing, M., Malicdan, M. C. V., Wang, J. A., Pri‐Chen, H., Hess, R. A., Fischer, R. E., O’Brien, K., Merideth, M. A., Gahl, W. A., & Gochuico, B. R. (2020) · Human Mutation · doi:10.1002/humu.23968 · Cited by 125
The female protective effect against autism spectrum disorder
Wigdor, E. M., Weiner, D. J., Grove, J., Fu, J. M., Thompson, W. K., Carey, C. E., Baya, N., van der Merwe, C., Walters, R. K., Satterstrom, F. K., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100134 · Cited by 124
Self-citationThe female protective effect against autism spectrum disorder
Wigdor, E. M., Weiner, D. J., Grove, J., Fu, J. M., Thompson, W. K., Carey, C. E., Baya, N., van der Merwe, C., Walters, R. K., Satterstrom, F. K., et al. (2021) · doi:10.1101/2021.03.29.21253866 · Cited by 124
Self-citationIndel variant analysis of short-read sequencing data with Scalpel
Fang, H., Bergmann, E. A., Arora, K. S., Vacic, V., Zody, M. C., Iossifov, I. H., O'Rawe, J., Wu, Y., Barrón, L. T. J., Rosenbaum, J., et al. (2016) · Nature Protocols · doi:10.1038/nprot.2016.150 · Cited by 124
Self-citationThe contributions of rare inherited and polygenic risk to ASD in multiplex families
Cirnigliaro, M., Chang, T. S., Arteaga, S. A., Pérez‐Cano, L., Ruzzo, E. K., Gordon, A., Bicks, L. K., Jung, J.-Y., Lowe, J. K., Wall, D. P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215632120 · Cited by 124
Developmental activities of the complement pathway in migrating neurons
Gorelik, A., Sapir, T., Haffner‐Krausz, R., Olender, T., Woodruff, T. M., & Reiner, O. (2017) · Nature Communications · doi:10.1038/ncomms15096 · Cited by 123
Qi, H., Yu, L., Zhou, X., Wynn, J., Zhao, H., Guo, Y., Zhu, N., Kitaygorodsky, A., Hernan, R., Aspelund, G., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007822 · Cited by 122
Self-citationDe Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions
Mencacci, N. E., Kamsteeg, E.-J., Nakashima, K., R’Bibo, L., Lynch, D. S., Balint, B., Willemsen, M. A. A. P., Adams, M. E., Wiethoff, S., Suzuki, K., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.02.015 · Cited by 122
Epigenetics of Autism Spectrum Disorder
Siu, M. T., & Weksberg, R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-53889-1_4 · Cited by 121
Elevated polygenic burden for autism is associated with differential DNA methylation at birth
Hannon, E. J., Schendel, D., Ladd‐Acosta, C., Grove, J., iPSYCH-Broad ASD Group, Hansen, C. S., Andrews, S. V., HOUGAARD, D. M., Bresnahan, M. A., Mors, O. N., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0527-4 · Cited by 121
Thalamic Reticular Dysfunction as a Circuit Endophenotype in Neurodevelopmental Disorders
Krol, A., Wimmer, R. D., Halassa, M. M., & Feng, G. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.021 · Cited by 121
Blok, L. S., Rousseau, J., Twist, J., Ehresmann, S., Takaku, M., Venselaar, H., Rodan, L. H., Nowak, C. B., Douglas, J., Swoboda, K. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06014-6 · Cited by 121
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons
Marro, S. G., Chanda, S., Yang, N., Janas, J. A., Valperga, G., Trotter, J. H., Zhou, B., Merrill, S. A., Yousif, I., Shelby, H., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.043 · Cited by 120
Wang, S., Mandell, J. D., Kumar, Y., Sun, N., Morris, M. T., Arbelaez, J., Nasello, C., Dong, S., Duhn, C., Zhao, X., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.082 · Cited by 120
Self-citationGonatopoulos-Pournatzis, T., Niibori, R., Salter, E. W., Weatheritt, R. J., Tsang, B., Farhangmehr, S., Liang, X., Braunschweig, U., Roth, J. F., Zhang, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.006 · Cited by 120
De novo variants in neurodevelopmental disorders—experiences from a tertiary care center
Brunet, T., Jech, R., Brügger, M., Kovacs, R., Alhaddad, B., Leszinski, G. S., Riedhammer, K. M., Westphal, D. S., Mahle, I., Mayerhanser, K., et al. (2021) · Clinical Genetics · doi:10.1111/cge.13946 · Cited by 119
Chromosomal contacts connect loci associated with autism, BMI and head circumference phenotypes
2p15 Consortium, Loviglio, M. N., 16p11.2 Consortium, Leleu, M., Männik, K., Passeggeri, M., Giannuzzi, G., van der Werf, I., Waszak, S. M., Zazhytska, M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.84 · Cited by 118
Exome sequencing and whole genome sequencing for the detection of copy number variation
Hehir‐Kwa, J. Y., Pfundt, R., & Veltman, J. A. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1053467 · Cited by 117
Kaat, A. J., Shui, A. M., Ghods, S. S., Farmer, C. A., Esler, A. N., Thurm, A., Georgiades, S., Kanne, S. M., Lord, C., Kim, Y. S., et al. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13242 · Cited by 116
Functional significance of rare neuroligin 1 variants found in autism
Nakanishi, M., Nomura, J., Ji, X., Tamada, K., Arai, T., Takahashi, E., Bućan, M., & Takumi, T. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006940 · Cited by 115
Petrovski, S., Küry, S., Myers, C. T., Anyane-Yeboa, K., Cogné, B., Bialer, M., Xia, F., Hemati, P., Riviello, J., Mehaffey, M., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.011 · Cited by 114
Mossink, B., Negwer, M., Schubert, D., & Nadif Kasri, N. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03714-5 · Cited by 114
Pugsley, K., Scherer, S. W., Bellgrove, M. A., & Hawi, Z. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01142-w · Cited by 114
Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
Montanari, M., Martella, G., Bonsi, P., & Meringolo, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073861 · Cited by 114
Ramaswami, G., Won, H., Gandal, M. J., Haney, J., Wang, J. C., Wong, C. C. Y., Sun, W., Prabhakar, S., Mill, J., & Geschwind, D. H. (2020) · Nature Communications · doi:10.1038/s41467-020-18526-1 · Cited by 113
7SK-BAF axis controls pervasive transcription at enhancers
Flynn, R. A., Do, B. T., Rubin, A. J., Calo, E., Lee, B., Kuchelmeister, H. Y., Rale, M. J., Chu, C., Kool, E. T., Wysocka, J., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3176 · Cited by 113
Lehman, A., Thouta, S., Mancini, G. M. S., Naidu, S., van Slegtenhorst, M., McWalter, K. M., Person, R., Mwenifumbo, J. C., Salvarinova, R., Guella, I., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.05.016 · Cited by 113
Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders
Gillentine, M. A., Wang, T., Hoekzema, K., Rosenfeld, J. A., Liu, P., Guo, H., Kim, C. N., Vries, B. B. A. D., Vissers, L. E. L. M., Nordenskjöld, M., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00870-6 · Cited by 113
Reijnders, M. R. F., Zachariadis, V., Latour, B. L., Jolly, L. A., Mancini, G. M. S., Pfundt, R., Wu, K. M., van Ravenswaaij‐Arts, C. M. A., Veenstra‐Knol, H. E., Anderlid, B., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.12.015 · Cited by 112
Kim, J., Shinde, D. N., Reijnders, M. R. F., Hauser, N. S., Belmonte, R. L., Wilson, G. R., Bosch, D. G. M., Bubulya, P. A., Shashi, V., Petrovski, S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.06.029 · Cited by 112
An Organismal CNV Mutator Phenotype Restricted to Early Human Development
Liu, P., Yuan, B., Carvalho, C. M. B., Wüster, A., Walter, K., Zhang, L., Gambin, T., Chong, Z., Campbell, I. M., Coban‐Akdemir, Z., et al. (2017) · Cell · doi:10.1016/j.cell.2017.01.037 · Cited by 112
Self-citationIRF2BPL Is Associated with Neurological Phenotypes
Marcogliese, P. C., Shashi, V., Spillmann, R. C., Stong, N., Rosenfeld, J. A., Koenig, M. K., Martínez-Agosto, J. A., Herzog, M. R., Chen, A. H., Dickson, P., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.07.006 · Cited by 115
Metadata
- Authors
- Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., Smith, J. D., Paeper, B., Nickerson, D. A., Dea, J., Dong, S., Gonzalez, L. E., Mandell, J. D., Mane, S. M., Murtha, M. T., Sullivan, C. A., Walker, M. F., Waqar, Z., Wei, L., Willsey, A. J., Yamrom, B., Lee, Y.-H., Grabowska, E., Dalkic, E., Wang, Z., Marks, S., Andrews, P., Leotta, A., Kendall, J., Hakker, I., Rosenbaum, J., Ma, B., Rodgers, L., Troge, J., Narzisi, G., Yoon, S., Schatz, M. C., Ye, K., McCombie, W. R., Shendure, J., Eichler, E. E., State, M. W., & Wigler, M.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Oregon Health & Science University (US)
- University of California, San Francisco (US)
- University of Washington (US)
- Peking University (CN)
- Yale University (US)
- Albert Einstein College of Medicine (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Shendure, Jay
- Eichler, Evan E.
- State, Matthew W.
- Wigler, Michael
- ORCID
- Iossifov, Ivan
- O’Roak, Brian J.
- Sanders, Stephan J.
- Ronemus, Michael
- Krumm, Niklas
- Stessman, Holly A.
- Patterson, Karynne E.
- Smith, Joshua D.
- Nickerson, Deborah A.
- Dea, Jeanselle
- Dong, Shan
- Mandell, Jeffrey D.
- Mane, Shrikant M.
- Sullivan, Catherine A.
- Wei, Liping
- Willsey, A. Jeremy
- Yamrom, Boris
- Rodgers, Linda
- Narzisi, Giuseppe
- Schatz, Michael C.
- Ye, Kenny
- McCombie, W. Richard
- Shendure, Jay
- Eichler, Evan E.
- State, Matthew W.
- Wigler, Michael
- Venue
- Nature
- Published
- 2014-10-29
- Volume
- 515
- Issue
- 7526
- Pages
- 216-221
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4313871
- OpenAlex
- W2008627757
- Cited by
- 2,585
- References
- 51
- Citations by year
- 2026: 125 · 2025: 178 · 2024: 204 · 2023: 209 · 2022: 263 · 2021: 266 · 2020: 298 · 2019: 232 · 2018: 202 · 2017: 237 · 2016: 210 · 2015: 146 · 2014: 12
- FWCI
- 112.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Zonguldak Bülent Ecevit University Institutional Repository (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (1rc2hl103010-01, UL1TR000142)
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (RC2HL102925, RC2HL102926, RC2HL102923, UC2HL102924, RC2HL-103010, UC2HL102925, UC2HL102923, UC2HL103010, RC2HL102924, UC2HL102926)
- National Institute of Mental Health (R01MH101221)
- National Institute of General Medical Sciences (T32GM007266)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- autism spectrum disorder, de novo mutations, simplex families, missense mutations, copy number variation, sex differences, intellectual disability, schizophrenia, chromatin modifiers, exome sequencing, genetic architecture, affected siblings, synaptic genes, chromatin remodeling
- MeSH terms
- Child, Child Development Disorders, Pervasive, Female, Genes, Humans, Intelligence Tests, Male, Mutation, Reproducibility of Results, Cluster Analysis, Open Reading Frames, Genetic Predisposition to Disease, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
